Clinical Trial Update: Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers [NA]

View source ↗

Summary

This completed clinical trial evaluated screening methods to detect tumors in SDH-positive carriers, addressing hereditary paraganglioma and pheochromocytoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Snippet

Sponsor: University Hospital, Angers | Conditions: Paraganglioma, Pheochromocytoma | NA | Status: COMPLETED